The isolation and identification of the asymmetrical disulfide of L-cysteine and L-homocysteine, hereafter referred to as "mixed disulfide," were previously described (1) . At that time the amino acid had been found only in the urine of patients with cystinuria.
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Radioactivity in fractions of column effluent was determined by liquid scintillation counting. Two-ml fractions were poured directly into counting vials, and the fraction collection tubes were rinsed into the counting vials with 10 ml of a dioxane phosphor system.1 This method yielded an over-all counting efficiency of 30%o.
For identification of mixed disulfide in urine, fractions were collected by the stream-splitting technique. The pooled fractions containing the material were desalted on Dowex 50 X 4 (H+) (7) and evaporated to dryness. The specimens were then subj ected to oxidation with performic acid (8) , and the resultant cysteic and homocysteic acids were determined by 2-dimensional paper chromatography, with butanol: acetic acid: water (120: 30: 50) versus butanol: pyridine: water (1: 1: 1) (9).
The Ninhydrin colored spots were eluted with an ethanolic copper sulfate solution and compared with standards in a spectrophotometer (10) .
Fifty Ac of L-methionine-S' with a SA of 17 ,uc per mg was administered orally to a cystinuria patient who was fasting and had just voided urine. This patient had no evidence of urinary calculi and was known to have normal renal function, including normal inulin clearance. During the 24 hours following administration of the isotope, urine was collected fractionally at 1.25 hours, 5 .25 hours, and 6.0 hours; the urine from 6 to 24 hours was collected in one vessel. Samples of each specimen were analyzed for total radioactivity by liquid scintillation counting. Cystine and mixed disulfide were isolated chromatographically on the 150-cm column, as previously described, from portions of the 0 to 1.25-, 5.25 to 6-, and 6 to 24-hour specimens. These fractions were desalted and lyophilized. Performic acid oxidation split the S-S bond (8) , and the specimens were dried on the rotary evaporator. Five-tenths ml of water was added to the flasks, and several different microliter amounts, in duplicate, were spotted on Whatman 3 filter paper for chromatography of the cysteic and homocysteic acids. Multiple amounts of standard solutions of these compounds were used for comparison. Descending chromatography with butanol: acetic acid: water (120: 30: 50) was run for 40 hours. This procedure resulted in the cysteic and homocysteic acids' running 185 and 220 mm, respectively, from the origin. Addition of nonoxidized, standard solutions of cystine and mixed disulfide revealed 1 Naphthalene, 50 g; 2,5-diphenyloxazole, 7 g; 1,4-bis-2-(4-methyl-5-phenyloxazolyl) benzene, 50 mg; and enough dioxane to make 1 L.
1956
DISULFIDE METABOLISM IN CYSTINURIA that these were separated from the cysteic and homocysteic acids. No unreacted cystine or mixed disulfide was encountered on the paper chromatograms. After color development, spots were eluted, and micromolar values were determined for cysteic and homocysteic acids by comparison with standards. The duplicate spots were eluted with 80% ethanol; radioactivity was determined by liquid scintillation counting. Recovery studies showed that the Ninhydrin reaction did not appreciably interfere with counting, and an over-all efficiency of 25%v was obtained.
For the infusion of the mixed disulfide into the tail vein of a rat, 20 mg was dissolved in 35 ml of 0.6%o saline with pH adjusted to 7.4 with sodium bicarbonate. A similar solution without amino acid was infused, and urine specimens were collected. The solution containing the amino acid was then substituted.
To study metabolism of the compound in a patient with cystinuria, radioactive mixed disulfide was prepared with S35 on the cysteine sulfur. This was done by sodium reduction of L-cystine-S3 2 in liquid NH3 (11) followed by reaction with L-homocysteine prepared from L-homocysteine thiolactone hydrochloride 3 (12) . The reaction mixture was brought to pH 7.5 with NaHCO3 and oxygenated at room temperature for 3 hours. The mixed disulfide, S' labeled, was chromatographically separated on an Amberlite IR-120 column from the reaction's other products, cystine-S35 and homocystine without label (1).
To minimize losses, it was elected to separate the material from the citrate buffer with an ion-exchange resin, rather than to attempt crystallization. Accordingly, fractions containing mixed disulfide were passed into a small column of Dowex 2 OH-washed with water; the compound was removed with N acetic acid (13) and lyophilized. Dissolved in water, samples of the material were assayed for radioactivity and amino acid content. Approximately 22.9 Ac was diluted in 100 ml of saline, autoclaved, and infused intravenously over a 4-hour period. Chromatography of this solution revealed that it also contained cystine, with 40%o of the radioactivity, and homocystine, which was not radioactive. Urine was collected from the beginning of the infusion. Urine sulfate was precipitated with benzidine (14) and counted on planchettes with a gas-flow counter. The over-all recovery and efficiency were 13.7%. Figure 1 ). To evaluate the possibility that the amino acid occurs normally but in trace concentrations, meastures were taken to increase the sensitivity for detection. Fifty ,tc of L-methionine-S35 was administered orally in a single dose to two subjects without liver or kidney disease. Blood, obtained at 6 and 24 hours, was immediately processed for ion-exchange chromatography. Urine was collected for 24 hours and preserved by refrigeration surgery. Patients had not recently suffered any complication, such as the passage of stones, since the latter might compromise the desirability of giving the patient a methionine load to increase blood concentrations of the mixed disulfide. Patients were preferably large people, so that a large catheter might be introduced to facilitate withdrawal of blood. Finally, the patients were volunteers for the procedure. In a preliminary study, a patient was not given a methionine load, and significant peaks of mixed disulfide were not detected. In another patient, the renal vein blood was obtained at the time of pyelolithotomy. Insignificant a-v differences were obtained; however, it became apparent that the kidney was not functioning, and nephrectomy was later required. The patient from whom data are reported was patient F. C. in Table II . This patient, who filled all the criteria listed above, excreted the highest amount of mixed disulfide and might have the highest blood levels. One limitation of the technique is that leaving the relatively large and stiff catheter in place for an extended period to perform concurrent renal clearance studies seemed unwise. To minimize any effect of water extraction, urinary flow was kept low by restricting fluids, and the urinary bladder was not catheterized for clearance studies. and the addition of thymol crystals. After chromatographic fractionation, 2.0 ml-fractions were examined for radioactivity. Peaks of radioactivity were found for sulfate, taurine, cystine, cystathionine, and methionine.5 Chromatography of the urine from one of these subjects showed a significant peak corresponding to the mixed disulfide. After corrections for efficiency and decay, 1.3 x 104 counts above background were found in the mixed disulfide area. This, in the 24 hours following administration, indicated that the subject excreted 0.012%o of the administered methionine as the mixed disulfide. Urine from the other subject revealed a few counts above background in the area under question, but these were not statistically significant. None of the plasma specimens contained any radioactivity either in the area of the mixed disulfide or of homocystine, whether or not air-oxidation of the -SH groups was performed (4).
To increase the concentration of the mixed disulfide for its determination in plasma, 12 g of L-methionine was given in divided oral doses on 2 successive days to a subject without liver or kidney disease. On the morning of the second day of nonradioactive methionine loading, he was given 50 uc of L-methionine-S35. Urine was collected throughout the day. Blood specimens were drawn at 2, 4, 6, and 24 hours to minimize the possibility of missing the peak of mixed disulfide activity in the blood plasma. The picric acid filtrates from each specimen were pooled, and 10 /moles of nonradioactive mixed disulfide was added as a carrier. Chromatography of 58.3 ml of the pooled plasma filtrate and counting as described revealed a significant radioactive peak (6.8 X 103 uncorrected counts above background) of the mixed disulfide. S35 peaks were also found for sulfate, taurine, cystine, cystathionine, and methionine (see footnote 5).
Occurrence of mixed disulfide in diseases other than cystinuria. To determine the specificity of the mixed disulfide for cystinuria, urine from several patients with other amino-acidurias was examined by chromatography. Occasionally, a small peak corresponding to mixed disulfide was seen in urine specimens obtained from patients with the Fanconi syndrome (Figure 1, B) or those with Wilson's disease (Figure 1, C) . These patients had a marked generalized amino-aciduria. In a child with the Fanconi syndrome (Patient 1) and an adult with Wilson's disease (Patient 2), the amounts of the compound were sufficiently large to calculate excretion and permit collection of fractions containing the mixed disulfide and further identify them (Table I ). In two other patients with the Fanconi syndrome, oral methionine loading was followed by disulfide excretion sufficient to permit chromatographic isolation and subsequent confirmation of the identity of the compound. An adult (Patient 3) received 15 g of L-methionine in divided doses daily for 2 days, and urine was collected during the second 24 hours. A child (Patient 4) was given a dose equivalent on a weight basis. The urine of Patient 3 had a small peak in the area corresponding to the mixed disulfide before methionine administration, but that of Patient 4 had none. In both of these patients there was a considerable peak corresponding to the mixed disulfide after methionine loading (Table I) . Fractions containing the substance were pooled, desalted, and subjected to performic acid oxidation and paper chromatography. Equimolar amounts of cysteic acid and homocysteic acid were demonstrated in the fractions from urine of all 4 patients.
Ion-exchange chromatography of deproteinized plasma from patients with uremia has been de- Occurrence of mixed disulfide in human and canine cystinuria. The mixed disulfide was invariably found in the urine of 15 patients with cystinuria (Figure 1, D) . Fifteen to 224 mg were excreted daily (Table II) . There was no consistent relationship to the amount of cystine, ornithine, lysine, or arginine excreted. Deproteinized plasma from these patients with cystinuria did not contain the mixed disulfide in amounts detectable by the Spackman, Stein, and Moore technique. Urine from a Dachshund with cystine calculi contained large amounts of cystine, ornithine, and lysine, but no arginine. There was a peak with the characteristics of mixed disulfide (Figure 1 , E).
Origin and metabolic fate of mixed disulfide. To determine the origin of the mixed disulfide, 50 ,uc of L-methionine-S35 was administered orally to a patient with cystinuria, and urine was collected as the patient voided. The specific activities of the cysteic and homocysteic acids processed from mixed disulfide and from cystine in the urine are shown in Table III To explore the possibility that the mixed disulfide is excreted in cystinuria consequent to the absence of some mechanism for its normal disposal, S35-labeled, mixed disulfide was adminis- Table V. [In calculation of A-V/A, the areas under the curves for the various amino-acid peaks were used directly (identical amounts were chromatographed) rather than first calculating concentrations, a procedure which tends to "round off" numbers with a loss of sensitivity.] Cystine appeared to be extracted similarly to other amino acids, whereas cysteine was extracted to a supernormal degree. In addition, the mixed disulfide appeared to be cleared to a high degree. The results do not take into account water extraction by the kidney, which should not, however, invalidate the comparison between the various amino acids.
DISCUSSION
The experiments reported here permit comment on the significance of the new amino acid, the disulfide of L-cysteine and L-homocysteine. The demonstration of radioactive mixed disulfide in the urine of normal subjects after administering L-methionine-S35 suggests that the compound is normally excreted in trace amounts. When methionine turnover was increased by oral loading, the disulfide was also demonstrated in the plasma of a normal subject.
The spontaneous occurrence of a peak with the characteristics of the mixed disulfide in urines of patients with a generalized amino-aciduria also suggests that this is a "normal" amino acid which escapes into the urine in detectable quantities under special conditions. The identification of this peak by chromatographic demonstration of equimolar amounts of the oxidation products, cysteic acid and homocysteic acid, is evidence that this peak was the mixed disulfide. No other sulfurcontaining amino acid has been reported to occtupy the same position as the mixed disulfide in the Spackman, Stein, and Moore system (2) . Furthermore, the increase in magnitude of the peak following an oral load of methionine confirms the nature of the peak. The suggestion of presence of the mixed disulfide in the plasma of patients with advanced renal insufficiency further indicates that the amino acid has a wide distribution in trace amounts. The mixed disulfide was invariably found in the urine of patients with cystinuria. In 15 patients, the amounts excreted bore no correlation on a molar basis to other amino acids excreted. The amount of mixed disulfide excreted appeared to be related to methionine content of the diet. This was not specifically studied; however, those patients who were not treated with a low methionine (400 mg) diet excreted higher amounts of disulfide (Table II) . The compound's tendency to be unstable was noted, although this was not specifically studied. After administration of L-methionine-S35 to a patient with cystinuria, there were a few counts above background in the homocystine area of one chromatogram of urine. The large amount of cystine present compared to the small amount of mixed disulfide might suggest that the mixed disulfide arises by disulfide interchange between cystine and homocystine, exhausting the latter. However, that homocystine has not been found in this laboratory in freshly collected urines militates against this origin of the mixed disulfide. If the compound is merely another diamino amino acid cleared from the plasma of the cystinuria patient at a rate similar to the glomerular filtration rate, it should have sufficient concentration in the blood plasma, at least in the normal individual, to yield an easily detectable Ninhydrin peak. If, however, the mixed disulfide is cleared from plasma at a rate similar to the renal plasma flow, then difficulty might be anticipated in ap-1961 preciating the peak in plasma." This would imply renal tubular secretion or renal production of the amino acid. Renal tubular secretion of amino acids in cystinuria has been suggested by other studies in this laboratory (17) . Renal tubular secretion of amino acids under loading conditions has been shown in dogs by Webber, Brown, and
Pitts (18) and demonstrated in human fl-aminoisobutyric acid excretion by -Armstrong and coworkers ( 19) .
The origin of mixed disulfide from methionine in cystinuria is confirmed by the study in which L-methionine-S35 was administered to a patient. The urine obtained 1.25 hours after feeding the methionine-S35 had the highest specific activity of the mixed disulfide of all the specimens examined. The homocysteine sulfur had initially 9 times the specific activity of the cysteine sulfur, but with time these specific activities tended to become equal. Reasons for this might include, first, the contribution to the cysteine side of mixed disulfide by cysteine from other sources, and second, dilution of the labeled cysteine in a larger body pool than the pool for dilution of labeled homocysteine. Similarly, the specific activity of the cysteic acid from mixed disulfide was always higher than the specific activity of the cysteic acid from cystine. This might also be explained on the basis that cystine labeled with S35 was diluted in a larger body pool than was the mixed disulfide. sulfide to sulfate. The fraction of S35 excreted in 24 hours by the cystinuria patient who received S35 mixed disulfide and S35 cystine was similar to the fraction of S35 excreted in 24 hours by the patient with cystinuria who received L-methionine S35. The possibility of a difference in the rate of metabolism of mixed disulfide between the normal person and the patient with cystinuria cannot be answered from the available data.
The intermediary metabolism of the sulfurcontaining amino acids, as currently understood, does not provide for production of the mixed disulfide. Free cysteine has been demonstrated in deproteinized blood plasma (15) . The present study failed to demonstrate free homocysteine in deproteinized plasma or urine. Neither homocystine nor the mixed disulfide was produced by aeration at pH 7 of deproteinized plasma front either normal subjects or from patients with cystinuria after loading with L-methionine-S35. Homocysteine may, of course, be present in the plasma in amounts that are not detectable by these methods. The studies suggest that mixed disulfide is produced in the tissues and cleared rapidly from the blood by the kidneys in cystinuria. The site or sites of production cannot be determined from present data.
The study of renal extraction of amino acids helps to explain the difficulty in determining plasma concentrations despite large urinary excretion of the mixed disulfide. The compound is apparently extracted from the plasma at a rate greater than any other amino acid.
A by-product of this study was the observation that cystine (-S-S-) is handled by the kidneys similarly to other amino acids but cysteine (-SH) is extracted to a high degree. Consideration of this finding is interesting in light of the experiments of Brand, Cahill, and Harris, who demonstrated that feeding of cystine does not result in increased cystine excretion in cystinuria but that the fed cystine was found as urinary sulfate (20) . Also, Brigham, Stein, and Moore (15) and Frimpter and co-workers (17) have shown that cysteine is virtually absent from urine. These data give further support to the previous suggestion (17) that plasma cysteine is oxidized to cystine before its appearance as urinary cystine. The small extraction of cystine, like that of most amino acids, demonstrates a high degree of reab-sorption by the renal tubules and agrees with the observation of Rosenberg, Downing, and Segal that cystine does nlot compete with lysine, arginine, and ornithine for uptake by rat kidney slices, although the three basic amino acids do compete (21) . Crawhill, Scowen, and Watts have reported a remarkable and prompt reduction in urinary cystine in cystinuria by the administration of D-penicillamine (22, 23) . The cystine was accounted for by the excretion of the disulfide of L-cysteine and D-penicillamine. The present report suggests that the disulfide of cysteine and penicillamine (22, 23) The results of the present study are most compatible with asymmetrical disulfide's being a "normal" metabolite that exists in trace amounts in human blood plasma and urine. It is probably metabolized by the normal subject, largely to sulfate. In patients with cystinuria, large amounts are excreted into the urine. The exact mechanism of excretion has not been defined, but the observations suggest an abnormally high renal extraction of plasma mixed disulfide. This study does not take into account the possibility that different rates of formation of mixed disulfide may exist in the normal subject and in patients with cystinuria. It neither rules out nor confirms formation of cystine and the mixed disulfide in the kidneys or in the urinary tract. 2. The asymmetrical disulfide, labeled with S35, was excreted by a patient with cystinuria after administration of L-methionine-S35. The homocysteine sulfur was initially of higher specific activity than the cysteine sulfur.
3. Intravenously administered mixed disulfide was metabolized by a rat and apparently by a patient with cystinuria. 4 . It is proposed that the mixed disulfide arises through a mechanism whereby cysteine combines with homocysteine. The data suggest that the amino acid may be a normal metabolite. In cystinuria and in the generalized amino-acidurias, mixed disulfide seems to be cleared rapidly from the plasma by the kidney and appears in the urine.
5. Determination of renal venous and arterial concentrations of amino acids in cystinuria revealed that cystine is extracted to a degree similar to amino acids not considered to be involved in cystinuria. The plasma cysteine, however, is extracted to a high degree. This study suggests that urinary cystine arises largely from plasma cysteine in cystinuria. The asymmetrical disulfide also appears to be extracted to a high degree, although renal production of the amino acid is not ruled out.
